The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.
about
Impact of a Proprietary Standardized Olive Fruit Extract (SOFE) on Cardio-Ankle Vascular Index, Visual Analog Scale and C-Reactive Protein Assessments in Subjects with Arterial Stiffness RiskRole of circulating factors in cardiac aging.Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment armsStimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral TherapyThe role of infiltrating immune cells in dysfunctional adipose tissue.A perspective on structural and computational work on collagen.Nile Red Quantifier: a novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy.A comparison of heart rate variability, n-3 PUFA status and lipid mediator profile in age- and BMI-matched middle-aged vegans and omnivores.Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets.Heterogenous treatment effects: secrets for a reliable treat-to-target trial?Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
P2860
Q28821191-A560EB47-E738-4B3D-BF38-7E16C7202CDEQ30234641-4829B2E1-B6EA-448B-B925-E0C84BB48DBEQ36924697-BC229992-716E-4C38-9587-1A066289E4EEQ37513027-8DD2F305-BDF7-46F4-A48E-C2102D770C51Q38637700-12088492-CE25-4841-ACA2-D41352CDBE6CQ38973643-ADCBC6FE-4131-436E-A580-1FAD54E93DB2Q47126403-EA025B7A-D314-43D6-9F6C-1619DC3BE6B1Q47746939-41435AC3-F532-4B94-B9C2-EFA87EF11E86Q49833824-EF0B7415-1EE6-4FDE-8215-FBCF38EC31DCQ50089724-FBE021F8-50E5-4520-BDC3-1E76030281FDQ54980602-AD8ADAA8-FE72-43EC-933B-748AEC7A01D5Q58765329-8E30EE23-7E14-4C54-9D3E-8C559E8BA6B9
P2860
The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The role of inflammatory bioma ...... inflammation reduction trials.
@en
type
label
The role of inflammatory bioma ...... inflammation reduction trials.
@en
prefLabel
The role of inflammatory bioma ...... inflammation reduction trials.
@en
P2860
P356
P1476
The role of inflammatory bioma ...... inflammation reduction trials.
@en
P2093
Gabriella Passacquale
Paolo Di Giosia
P2860
P356
10.1093/CVR/CVV227
P50
P577
2015-09-25T00:00:00Z